Black Diamond Therapeutics, Inc vs Johnson & Johnson — Stock Comparison

BDTX
Black Diamond Therapeutics, Inc
$2.60
▼ 1.89%
vs
JNJ
Johnson & Johnson
$227.19
▼ 1.16%
Q·Score Winner
Black Diamond Therapeutics, Inc
BDTX8.3/10vs 7.1/10

Q·Score Breakdown

8.3
Bullish
Overall
7.1
Bullish
10
Quality
9.3
9.7
Health
6.5
6.5
Growth
5.1
6.9
Valuation
7.3
7.9
Sentiment
6.5
BDTX

High-quality business with 23% return on equity and 32% profit margins.

JNJ

High-quality business with 26% return on equity and 22% profit margins.

earnings contracting 53% year-over-year.

Analyst Consensus

BUY
Target $9.86 (+279.1%)
7 analysts
BUY
Target $252.42 (+11.1%)
24 analysts

Fundamentals

BDTX
JNJ
6.7×
Trailing P/E
26.3×
-2.5×
Forward P/E
17.9×
32.0%
Profit Margin
21.8%
100.0%
Gross Margin
68.0%
22.9%
ROE
26.4%
Revenue Growth
9.9%
Earnings Growth
-52.9%
3.39
Beta
0.33
Price / Book
$149M
Market Cap
$546.9B
$1 – $5
52-Week Range
$146 – $252

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →